The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2020 1
2019 2
2018 2
2017 1
2014 4
2011 1

Africa 1
Uganda 2

Journal Article 12

1 - 12 of 12 Results

Refine Results

Refine Results:

Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses

CITE Title : Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses Personal Author(s) : Harmon, Jessica R.;Barbeau, Dominique J.;Nichol, Stuart T.;Spiropoulou, Christina F.;McElroy, Anita K.; Published Date : February 28 2020 Source : NPJ Vaccines. 5 URL : https://stacks.cdc.gov/view/cdc/89322 Harmon, Jessica R. et al. (2020). Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses. 5 Harmon, Jessica R. et al. "Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses" 5 (2020) Harmon, Jessica R. et al. "Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses" vol. 5, 2020 Export RIS Citation Information.

:

Harmon, Jessica R. ;

Barbeau, Dominique J.

February 28 2020 | NPJ Vaccines. 5

:

Rift Valley fever virus (RVFV) is a zoonotic arbovirus of clinical significance in both livestock and humans. A formalin-inactivated virus preparation...
Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection

CITE Title : Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection Personal Author(s) : McElroy, Anita K.;Nichol, Stuart T.; Published Date : October 22 2011;1-05-; Source : Virology. 422(1):6-12 URL : https://stacks.cdc.gov/view/cdc/78276 McElroy, Anita K. and Nichol, Stuart T. (2011). Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. 422(1). McElroy, Anita K. and Nichol, Stuart T. "Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection" 422, no. 1 (2011) McElroy, Anita K. and Nichol, Stuart T. "Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection" vol. 422, no. 1, 2011 Export RIS Citation Information.

:

McElroy, Anita K. ;

Nichol, Stuart T.

October 22 2011 | Virology. 422(1):6-12

:

Rift Valley fever virus (RVFV) causes significant morbidity and mortality in humans and livestock throughout Africa and the Middle East. The clinical ...
Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease

CITE Title : Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease Personal Author(s) : McElroy, Anita K.;Erickson, Bobbie R.;Flietstra, Timothy D.;Rollin, Pierre E.;Nichol, Stuart T.;Towner, Jonathan S.;Spiropoulou, Christina F.; Published Date : Oct 2014 Source : Emerg Infect Dis. 20(10):1683-1690. URL : https://stacks.cdc.gov/view/cdc/25664 McElroy, Anita K. et al. (2014). Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease. 20(10). McElroy, Anita K. et al. "Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease" 20, no. 10 (2014) McElroy, Anita K. et al. "Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease" vol. 20, no. 10, 2014 Export RIS Citation Information.

:

McElroy, Anita K. ;

Erickson, Bobbie R.

Oct 2014 | Emerg Infect Dis. 20(10):1683-1690.

:

Outbreaks of Ebola virus disease (EVD) occur sporadically in Africa and are associated with high case-fatality rates. Historically, children have been...
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing

CITE Title : Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing Personal Author(s) : Shrivastava-Ranjan, Punya;Flint, Mike;Bergeron, Éric;McElroy, Anita K.;Chatterjee, Payel;Albariño, César G.;Nichol, Stuart T.;Spiropoulou, Christina F.; Published Date : May 01 2018 Source : mBio. 9(3). URL : https://stacks.cdc.gov/view/cdc/53865 Shrivastava-Ranjan, Punya et al. (2018). Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing. 9(3). Shrivastava-Ranjan, Punya et al. "Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing" 9, no. 3 (2018) Shrivastava-Ranjan, Punya et al. "Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing" vol. 9, no. 3, 2018 Export RIS Citation Information.

:

Shrivastava-Ranjan, Punya ;

Flint, Mike

May 01 2018 | mBio. 9(3).

:

Ebola virus (EBOV) infection is a major public health concern due to high fatality rates and limited effective treatments. Statins, widely used choles...
Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations

CITE Title : Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations Personal Author(s) : de St. Maurice, Annabelle;Harmon, Jessica;Nyakarahuka, Luke;Balinandi, Stephen;Tumusiime, Alex;Kyondo, Jackson;Mulei, Sophia;Namutebi, Annemarion;Knust, Barbara;Shoemaker, Trevor;Nichol, Stuart T.;McElroy, Anita K.;Spiropoulou, Christina F.; Published Date : May 04 2018 Source : PLoS Negl Trop Dis. 12(5) URL : https://stacks.cdc.gov/view/cdc/89855 de St. Maurice, Annabelle et al. (2018). Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations. 12(5). de St. Maurice, Annabelle et al. "Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations" 12, no. 5 (2018) de St. Maurice, Annabelle et al. "Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations" vol. 12, no. 5, 2018 Export RIS Citation Information.

:

de St. Maurice, Annabelle ;

Harmon, Jessica

May 04 2018 | PLoS Negl Trop Dis. 12(5)

:

Rift Valley fever virus is an arbovirus that affects both livestock and humans throughout Africa and in the Middle East. Despite its endemicity throug...
Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model

CITE Title : Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model Personal Author(s) : Dodd, Kimberly A.;McElroy, Anita K.;Jones, Tara L.;Zaki, Sherif R.;Nichol, Stuart T.;Spiropoulou, Christina F.; Published Date : Jun 12 2014 Source : PLoS Negl Trop Dis. 2014; 8(6). URL : https://stacks.cdc.gov/view/cdc/27261 Dodd, Kimberly A. et al. (2014). Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model. 8(6). Dodd, Kimberly A. et al. "Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model" 8, no. 6 (2014) Dodd, Kimberly A. et al. "Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model" vol. 8, no. 6, 2014 Export RIS Citation Information.

:

Dodd, Kimberly A. ;

McElroy, Anita K.

Jun 12 2014 | PLoS Negl Trop Dis. 2014; 8(6).

:

BackgroundRift Valley fever virus (RVFV) causes outbreaks of severe disease in livestock and humans throughout Africa and the Arabian Peninsula. In pe...
Reply to Fedson

CITE Title : Reply to Fedson Personal Author(s) : McElroy, Anita K.;Spiropoulou, Christina F.; Published Date : 2-15- Source : J Infect Dis. 211(4):662-663 URL : https://stacks.cdc.gov/view/cdc/34966 McElroy, Anita K. and Spiropoulou, Christina F. (2014). Reply to Fedson. 211(4). McElroy, Anita K. and Spiropoulou, Christina F. "Reply to Fedson" 211, no. 4 (2014) McElroy, Anita K. and Spiropoulou, Christina F. "Reply to Fedson" vol. 211, no. 4, 2014 Export RIS Citation Information.

:

McElroy, Anita K. ;

Spiropoulou, Christina F.

2-15- | J Infect Dis. 211(4):662-663

No Description
SARS-CoV-2 Antibody Response is Associated with Age and Body Mass Index in Convalescent Outpatients

CITE Title : SARS-CoV-2 Antibody Response is Associated with Age and Body Mass Index in Convalescent Outpatients Personal Author(s) : Zhai, Bo;Clarke, Karen;Bauer, David L.;Moehling Geffel, Krissy K.;Kupul, Saran;Schratz, Lucas J.;Nowalk, M. Patricia;McElroy, Anita K.;McLachlan, James B.;Zimmerman, Richard K.;Alcorn, John F.; Published Date : 4 01 2022;4-01-; Source : J Immunol. 208(7):1711-1718 URL : https://stacks.cdc.gov/view/cdc/116011 Zhai, Bo et al. (2022). SARS-CoV-2 Antibody Response is Associated with Age and Body Mass Index in Convalescent Outpatients. 208(7). Zhai, Bo et al. "SARS-CoV-2 Antibody Response is Associated with Age and Body Mass Index in Convalescent Outpatients" 208, no. 7 (2022) Zhai, Bo et al. "SARS-CoV-2 Antibody Response is Associated with Age and Body Mass Index in Convalescent Outpatients" vol. 208, no. 7, 2022 Export RIS Citation Information.

:

Zhai, Bo ;

Clarke, Karen

4 01 2022 | J Immunol. 208(7):1711-1718

:

COVID-19 has had an unprecedented global impact on human health. Understanding the Ab memory responses to infection is one tool needed to effectively ...
Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice

CITE Title : Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice Personal Author(s) : Welch, Stephen R.;Ritter, Jana M.;McElroy, Anita K.;Harmon, Jessica R.;Coleman-McCray, JoAnn D.;Scholte, Florine E. M.;Kobinger, Gary P.;Bergeron, Éric;Zaki, Sherif R.;Nichol, Stuart T.;Spengler, Jessica R.;Spiropoulou, Christina F.; Published Date : December 02 2019 Source : PLoS Pathog. 15(12) URL : https://stacks.cdc.gov/view/cdc/89858 Welch, Stephen R. et al. (2019). Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice. 15(12). Welch, Stephen R. et al. "Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice" 15, no. 12 (2019) Welch, Stephen R. et al. "Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice" vol. 15, no. 12, 2019 Export RIS Citation Information.

:

Welch, Stephen R. ;

Ritter, Jana M.

December 02 2019 | PLoS Pathog. 15(12)

:

Crimean-Congo hemorrhagic fever virus (CCHFV, order Bunyavirales, family Nairoviridae, genus Orthonairovirus) is the tick-borne etiological agent of C...
Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1

CITE Title : Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1 Personal Author(s) : McElroy, Anita K.;Shrivastava-Ranjan, Punya;Harmon, Jessica R.;Martines, Roosecelis B.;Silva-Flannery, Luciana;Flietstra, Timothy D.;Kraft, Colleen S.;Mehta, Aneesh K.;Lyon, G. Marshall;Varkey, Jay B.;Ribner, Bruce S.;Nichol, Stuart T.;Zaki, Sherif R.;Spiropoulou, Christina F.; Published Date : Feb 2019 Source : Emerg Infect Dis. 25(2):290-298 URL : https://stacks.cdc.gov/view/cdc/75857 McElroy, Anita K. et al. (2019). Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1. 25(2). McElroy, Anita K. et al. "Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1" 25, no. 2 (2019) McElroy, Anita K. et al. "Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1" vol. 25, no. 2, 2019 Export RIS Citation Information.

:

McElroy, Anita K. ;

Shrivastava-Ranjan, Punya

Feb 2019 | Emerg Infect Dis. 25(2):290-298

:

Ebola virus disease (EVD) is associated with elevated cytokine levels, and hypercytokinemia is more pronounced in fatal cases. This type of hyperinfla...
Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda

CITE Title : Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda Personal Author(s) : Amman, Brian R.;Nyakarahuka, Luke;McElroy, Anita K.;Dodd, Kimberly A.;Sealy, Tara K.;Schuh, Amy J.;Shoemaker, Trevor R.;Balinandi, Stephen;Atimnedi, Patrick;Kaboyo, Winyi;Nichol, Stuart T.;Towner, Jonathan S.; Published Date : Oct 2014 Source : Emerg Infect Dis. 20(10):1761-1764. URL : https://stacks.cdc.gov/view/cdc/25675 Amman, Brian R. et al. (2014). Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda. 20(10). Amman, Brian R. et al. "Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda" 20, no. 10 (2014) Amman, Brian R. et al. "Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda" vol. 20, no. 10, 2014 Export RIS Citation Information.

:

Amman, Brian R. ;

Nyakarahuka, Luke

Oct 2014 | Emerg Infect Dis. 20(10):1761-1764.

No Description
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease

CITE Title : First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease Personal Author(s) : Dörnemann, Jenny;Burzio, Chiara;Ronsse, Axelle;Sprecher, Armand;De Clerck, Hilde;Van Herp, Michel;Kolié, Marie-Claire;Yosifiva, Vesselina;Caluwaerts, Severine;McElroy, Anita K.;Antierens, Annick; Published Date : Jan 15 2017 Source : J Infect Dis. 215(2):171-174. URL : https://stacks.cdc.gov/view/cdc/48011 Dörnemann, Jenny et al. (2017). First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease. 215(2). Dörnemann, Jenny et al. "First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease" 215, no. 2 (2017) Dörnemann, Jenny et al. "First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease" vol. 215, no. 2, 2017 Export RIS Citation Information.

:

Dörnemann, Jenny ;

Burzio, Chiara

Jan 15 2017 | J Infect Dis. 215(2):171-174.

:

A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. The patient was treated with monocl...